She started at the lowest dose, experienced mild nausea for the first two weeks, and now maintains stable glucose levels with 12% weight loss at 6 months
Snchez-de la Torre et al., 2022)
Tedi Totojani, then a Yale research fellow
This makes the theoretical benefits of microdosing smaller compared to shorter half-life medications like tirzepatide
Until now, the program wouldnt cover any GLP-1 weight loss drugs, such as Ozempic and Mounjaro, unless you were overweight and had another ailment that GLP-1s can treat, such as type 2 diabetes
This extends to any language implying regulatory approval that doesnt exist in the specific context being sold